BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16107759)

  • 1. Regulation of mast cell development.
    Shiohara M; Koike K
    Chem Immunol Allergy; 2005; 87():1-21. PubMed ID: 16107759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin augments stem cell factor-dependent growth of human mast cells from bone marrow multipotential hematopoietic progenitors.
    Sawai N; Koike K; Mwamtemi HH; Kinoshita T; Kurokawa Y; Sakashita K; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Ito S; Kato T; Miyazaki H; Yamashita T; Komiyama A
    Blood; 1999 Jun; 93(11):3703-12. PubMed ID: 10339477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor.
    Matsuzawa S; Sakashita K; Kinoshita T; Ito S; Yamashita T; Koike K
    J Immunol; 2003 Apr; 170(7):3461-7. PubMed ID: 12646606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines regulate development of human mast cells from hematopoietic progenitors.
    Nakahata T; Toru H
    Int J Hematol; 2002 May; 75(4):350-6. PubMed ID: 12041663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 directly modulates stem cell factor-dependent development of human mast cells derived from CD34(+) cord blood cells.
    Kinoshita T; Sawai N; Hidaka E; Yamashita T; Koike K
    Blood; 1999 Jul; 94(2):496-508. PubMed ID: 10397717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid is a negative regulator for the differentiation of cord blood-derived human mast cell progenitors.
    Kinoshita T; Koike K; Mwamtemi HH; Ito S; Ishida S; Nakazawa Y; Kurokawa Y; Sakashita K; Higuchi T; Takeuchi K; Sawai N; Shiohara M; Kamijo T; Kawa S; Yamashita T; Komiyama A
    Blood; 2000 May; 95(9):2821-8. PubMed ID: 10779427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An increase in circulating mast cell colony-forming cells in asthma.
    Mwamtemi HH; Koike K; Kinoshita T; Ito S; Ishida S; Nakazawa Y; Kurokawa Y; Shinozaki K; Sakashita K; Takeuchi K; Shiohara M; Kamijo T; Yasui Y; Ishiguro A; Kawano Y; Kitano K; Miyazaki H; Kato T; Sakuma S; Komiyama A
    J Immunol; 2001 Apr; 166(7):4672-7. PubMed ID: 11254727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human (rh)IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors.
    Oskeritzian CA; Wang Z; Kochan JP; Grimes M; Du Z; Chang HW; Grant S; Schwartz LB
    J Immunol; 1999 Nov; 163(9):5105-15. PubMed ID: 10528217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of 'adult-type' mast cells derived from human bone marrow CD34(+) cells cultured in the presence of stem cell factor and interleukin-6. Interleukin-4 is not required for constitutive expression of CD54, Fc epsilon RI alpha and chymase, and CD13 expression is reduced during differentiation.
    Shimizu Y; Sakai K; Miura T; Narita T; Tsukagoshi H; Satoh Y; Ishikawa S; Morishita Y; Takai S; Miyazaki M; Mori M; Saito H; Xia H; Schwartz LB
    Clin Exp Allergy; 2002 Jun; 32(6):872-80. PubMed ID: 12047434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin alone or in the presence of stem cell factor supports the growth of KIT(CD117)low/ MPL(CD110)+ human mast cells from hematopoietic progenitor cells.
    Kirshenbaum AS; Akin C; Goff JP; Metcalfe DD
    Exp Hematol; 2005 Apr; 33(4):413-21. PubMed ID: 15781331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of CD34+ subsets derived from bone marrow, umbilical cord blood and mobilized peripheral blood after stem cell factor and interleukin 3 stimulation.
    De Bruyn C; Delforge A; Lagneaux L; Bron D
    Bone Marrow Transplant; 2000 Feb; 25(4):377-83. PubMed ID: 10723580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cofactors are essential for stem cell factor-dependent growth and maturation of mast cell progenitors: comparative effects of interleukin-3 (IL-3), IL-4, IL-10, and fibroblasts.
    Rennick D; Hunte B; Holland G; Thompson-Snipes L
    Blood; 1995 Jan; 85(1):57-65. PubMed ID: 7528573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential responsiveness of purified mouse c-kit+ mast cells and their progenitors to IL-3 and stem cell factor.
    Lantz CS; Huff TF
    J Immunol; 1995 Oct; 155(8):4024-9. PubMed ID: 7561112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method to generate and culture human mast cells: Peripheral CD34+ stem cell-derived mast cells (PSCMCs).
    Schmetzer O; Valentin P; Smorodchenko A; Domenis R; Gri G; Siebenhaar F; Metz M; Maurer M
    J Immunol Methods; 2014 Nov; 413():62-8. PubMed ID: 25038510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of short term in vitro cultured human mast cells from different progenitors - Peripheral blood-derived progenitors generate highly mature and functional mast cells.
    Andersen HB; Holm M; Hetland TE; Dahl C; Junker S; Schiøtz PO; Hoffmann HJ
    J Immunol Methods; 2008 Jul; 336(2):166-74. PubMed ID: 18538784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven week culture of functional human mast cells from buffy coat preparations.
    Holm M; Andersen HB; Hetland TE; Dahl C; Hoffmann HJ; Junker S; Schiøtz PO
    J Immunol Methods; 2008 Jul; 336(2):213-21. PubMed ID: 18547584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of human mast cells from bone-marrow and cord-blood progenitor cells by factors produced by a mouse stromal cell line.
    Arock M; Hervatin F; Guillosson JJ; Mencia-Huerta JM; Thierry D
    Ann N Y Acad Sci; 1994 May; 725():59-68. PubMed ID: 7518213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of tryptase-, chymase+ cells in human CD34 bone marrow progenitors.
    Shimizu Y; Suga T; Maeno T; Tsukagoshi H; Kawata T; Narita T; Takahashi T; Ishikawa S; Morishita Y; Nakajima T; Hara F; Miura T; Kurabayashi M
    Clin Exp Allergy; 2004 Nov; 34(11):1719-24. PubMed ID: 15544596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.